keyword
https://read.qxmd.com/read/38266937/therapeutic-effect-of-5-asa-and-hesperidin-loaded-chitosan-eudragit%C3%A2-s100-nanoparticles-as-a-ph-sensitive-carrier-for-local-targeted-drug-delivery-in-a-rat-model-of-ulcerative-colitis
#21
JOURNAL ARTICLE
Armana Abdollahy, Majid Salehi, Solmaz Mahami, Andreas Bernkop-Schnürch, Hamid Vahedi, Anneh Mohammad Gharravi, Mohsen Mehrabi
Ulcerative colitis (UC) is an idiopathic disease characterized by colonic mucosal tissue destruction secondary to an excessive immune response. We synthesized pH-sensitive cross-linked chitosan/Eudragit® S100 nanoparticles (EU S100/CS NPs) as carriers for 5-aminosalicylic acid (5-ASA) and hesperidin (HSP), then conducted in-vitro and in-vivo studies and evaluated the therapeutic effects. In-vitro analysis revealed that the 5-ASA-loaded EU S100/CS NPs and the HSP-loaded EU S100/CS NPs had smooth and curved surfaces and ranged in size between 250 and 300 nm, with a zeta potential of 32 to 34 mV...
January 22, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38255764/involvement-of-embryo-derived-and-monocyte-derived-intestinal-macrophages-in-the-pathogenesis-of-inflammatory-bowel-disease-and-their-prospects-as-therapeutic-targets
#22
REVIEW
Shujun Zuo, Liping Jiang, Luying Chen, Weikang Wang, Jintao Gu, Jiajie Kuai, Xuezhi Yang, Yang Ma, Chenchen Han, Wei Wei
Inflammatory bowel disease (IBD) is a group of intestinal inflammatory diseases characterized by chronic, recurrent, remitting, or progressive inflammation, which causes the disturbance of the homeostasis between immune cells, such as macrophages, epithelial cells, and microorganisms. Intestinal macrophages (IMs) are the largest population of macrophages in the body, and the abnormal function of IMs is an important cause of IBD. Most IMs come from the replenishment of blood monocytes, while a small part come from embryos and can self-renew...
January 5, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38235331/design-synthesis-and-mechanistic-anticancer-activity-of-new-acetylated-5-aminosalicylate-thiazolinone-hybrid-derivatives
#23
JOURNAL ARTICLE
Wafaa S Ramadan, Maha M Saber-Ayad, Ekram Saleh, Hajjaj H M Abdu-Allah, Abdel-Nasser A El-Shorbagi, Varsha Menon, Hamadeh Tarazi, Mohammad H Semreen, Nelson C Soares, Shirin Hafezi, Thenmozhi Venkatakhalam, Samrein Ahmed, Osamu Kanie, Rifat Hamoudi, Raafat El-Awady
The development of hybrid compounds has been widely considered as a promising strategy to circumvent the difficulties that emerge in cancer treatment. The well-established strategy of adding acetyl groups to certain drugs has been demonstrated to enhance their therapeutic efficacy. Based on our previous work, an approach of accommodating two chemical entities into a single structure was implemented to synthesize new acetylated hybrids ( HH32 and HH33 ) from 5-aminosalicylic acid and 4-thiazolinone derivatives...
January 19, 2024: IScience
https://read.qxmd.com/read/38191328/efficacy-and-safety-of-tacrolimus-in-older-adults-with-ulcerative-colitis-a-retrospective-study
#24
JOURNAL ARTICLE
Ayumi Ito, Syun Murasugi, Teppei Omori, Shinichi Nakamura, Katsutoshi Tokushige
BACKGROUND/AIMS: The prevalence of ulcerative colitis (UC) has been increasing, also in older adults. Here, we retrospectively compared the efficacy and safety of tacrolimus (TAC) in older and younger patients with UC. METHODS: We included younger (age < 65 years; n = 116) and older patients (age ≥ 65 years; n = 21) with UC who received TAC from April 2009 through December 2022(mean follow-up, 1230 ± 175 days) and achieved remission...
January 8, 2024: BMC Gastroenterology
https://read.qxmd.com/read/38185603/gastrointestinal-beh%C3%A3-et-s-disease-manifestations-diagnosis-and-management
#25
JOURNAL ARTICLE
Zara Manuelyan, Edward Butt, Sreeram Parupudi
Behçet's disease (BD) is a rare, inflammatory vascular disorder with recurrent oral and genital aphthous ulcers, along with ocular and cutaneous manifestations. Gastrointestinal (GI) BD may involve any portion of the GI tract. However, it is commonly described in the terminal ileum, followed by the ileocecal region. Diagnosis is challenging given lack of pathognomonic tests; therefore, it is based on clinical criteria. Management of intestinal BD includes different classes of medications including corticosteroids, 5-aminosalicylic acid, immunomodulators, and anti-tumor necrosis factor alpha monoclonal antibody agents...
January 6, 2024: Disease-a-month: DM
https://read.qxmd.com/read/38180710/takayasu-s-arteritis-associated-with-crohn-s-disease-treated-with-infliximab
#26
JOURNAL ARTICLE
Hiroyuki Ariga, Yusuke Chino, Takeshi Ojima, Satoshi Suzuki, Kenta Okada, Junya Kashimura
A 23-year-old woman presented with fever, diarrhea, bloody stools, and arthralgia that did not improve despite previous treatments and was diagnosed with Crohn's disease. Remission was achieved after the introduction of infliximab, nutritional therapy, and 5-aminosalicylic acid treatment. However, the patient's blood sedimentation rate remained elevated without symptom recurrence, except for abdominal pain in the following year. Aortic wall thickening in the thoracic descending aorta was also observed on computed tomography...
January 5, 2024: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38171875/an-elderly-patient-developed-ulcerative-colitis-after-sars-cov-2-mrna-vaccination-a-case-report-and-review-of-the-literature
#27
JOURNAL ARTICLE
Takahito Shimada, Jun Takada, Atsushi Baba, Masahide Iwashita, Takao Hayashi, Akio Maeda, Masahito Shimizu
An 86-year-old man presented to our hospital with symptoms of diarrhea and bloody stool, which had manifested two weeks after receiving his third SARS-CoV-2 mRNA vaccination. Colonoscopy revealed diffuse, rough-surfaced mucosa extending from the ascending colon to the rectum. Despite attempting probiotic treatment, the patient's condition did not improve, leading to admission. Endoscopic findings at admission worsened. Based on endoscopic and histopathological findings, the patient was diagnosed with ulcerative colitis...
January 2, 2024: Internal Medicine
https://read.qxmd.com/read/38138595/oxidation-of-mesalamine-under-phenoloxidase-or-peroxidase-like-enzyme-catalysis
#28
JOURNAL ARTICLE
Rimaz El Zein, Pompilia Ispas-Szabo, Maziar Jafari, Mohamed Siaj, Mircea Alexandru Mateescu
Mesalamine, also called 5-ASA (5-aminosalicylic acid), is a largely used anti-inflammatory agent and is a main choice to treat Ulcerative Colitis. This report is aimed to investigate enzymatic processes involved in the oxidation of mesalamine to better understand some of its side-effects. Oxidation with oxygen (catalyzed by ceruloplasmin) or with hydrogen peroxide (catalyzed by peroxidase or hemoglobin) showed that these oxidases, despite their different mechanisms of oxidation, could recognize mesalamine as a substrate and trigger its oxidation to a corresponding quinone-imine...
December 15, 2023: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38110964/polystyrene-nanobeads-exacerbate-chronic-colitis-in-mice-involving-in-oxidative-stress-and-hepatic-lipid-metabolism
#29
JOURNAL ARTICLE
Juan Ma, Yin Wan, Lingmin Song, Luchen Wang, Huimei Wang, Yingzhi Li, Danfei Huang
BACKGROUND: Nanoplastics (NPs) are omnipresent in our lives as a new type of pollution with a tiny size. It can enter organisms from the environment, accumulate in the body, and be passed down the food chain. Inflammatory bowel disease (IBD) is a nonspecific intestinal inflammatory disease that is recurrent and prevalent in the population. Given that the intestinal features of colitis may affect the behavior and toxicity of NPs, it is imperative to clarify the risk and toxicity mechanisms of NPs in colitis models...
December 18, 2023: Particle and Fibre Toxicology
https://read.qxmd.com/read/38107181/new-nitazoxanide-derivatives-design-synthesis-biological-evaluation-and-molecular-docking-studies-as-antibacterial-and-antimycobacterial-agents
#30
JOURNAL ARTICLE
Mahmoud Saleh, Yaser A Mostafa, Jyothi Kumari, Momen M Thabet, Dharmarajan Sriram, Mahmoud Kandeel, Hajjaj H M Abdu-Allah
A new series inspired by combining fragments from nitazoxanide (NTZ) and 4-aminosalicylic acid (4-ASA) was synthesized and screened for in vitro antibacterial and antimycobacterial activities. The majority showed higher antibacterial potency than NTZ against all the screened strains, notably, 5f, 5j, 5n and 5o with MICs of 0.87-9.00 μM. Compounds 5c, 5n and 5o revealed higher potency than ciprofloxacin against K. pneumoniae , while 5i was equipotent. For E. faecalis , 3b, 5j, and 5k showed higher potency than ciprofloxacin...
December 13, 2023: RSC medicinal chemistry
https://read.qxmd.com/read/38106983/geographical-heterogeneity-in-the-disease-characteristics-and-management-of-patients-with-inflammatory-bowel-disease-the-preliminary-results-of-a-chinese-database-for-ibd-chase-ibd
#31
JOURNAL ARTICLE
Jian Wan, Jun Shen, Xiaoping Wu, Jie Zhong, Yan Chen, Lanxiang Zhu, Yinglei Miao, Naizhong Hu, Jie Chen, Jie Liang, Kaichun Wu
BACKGROUND: The incidence of inflammatory bowel disease (IBD) is rapidly increasing in China, a vast country with significant geographical differences. The socioeconomic status of Eastern China is significantly higher than that of Western China. OBJECTIVES: This study aimed to describe the geographical heterogeneity in the characteristics and management of patients with IBD in both Eastern and Western China. DESIGN: This was a multicenter, cross-sectional study...
2023: Therapeutic Advances in Gastroenterology
https://read.qxmd.com/read/38050911/the-prevalence-and-risk-factors-of-clostridioides-difficile-infection-in-inflammatory-bowel-disease-10-year-south-korean-experience-based-on-the-national-database
#32
JOURNAL ARTICLE
Eun Mi Song, Arum Choi, Sukil Kim, Sung Hoon Jung
BACKGROUND: Few studies evaluate the epidemiology and risk factors of Clostridioides difficile infection (CDI) in Asian patients with inflammatory bowel disease (IBD). We investigated the year-end prevalence, cumulative incidence and risk factors of CDI in Asian patients with IBD using a large-scale population-based cohort in Korea. METHODS: Using the National Health Insurance Service database, we identified patients with IBD and sex- and age-matched controls without IBD between 2008 and 2018...
December 4, 2023: Journal of Korean Medical Science
https://read.qxmd.com/read/38023976/concomitant-5-aminosalicylic-acid-treatment-does-not-affect-6-thioguanine-nucleotide-levels-in-patients-with-inflammatory-bowel-disease-on-thiopurines
#33
JOURNAL ARTICLE
Rahel Looser, Michael Doulberis, Jean-Benoit Rossel, Yannick Franc, Daniel Müller, Luc Biedermann, Gerhard Rogler
BACKGROUND: There are conflicting data as to whether co-treatment with 5-aminosalicylic acid (5-ASA) in patients with inflammatory bowel disease (IBD) under azathioprine (AZA) or 6-mercaptopurine (6-MP) therapy may influence 6-thioguanine nucleotide (6-TGN) concentrations, and whether this combination puts patients at risk of side-effects. The aim of the study was to determine 6-TGN levels in patients treated with AZA/6-MP, either alone or in combination with 5-ASA. METHODS: Available blood samples from patients treated with AZA or 6-MP were retrieved from the Swiss IBD Cohort Study (SIBDCS)...
2023: Annals of Gastroenterology: Quarterly Publication of the Hellenic Society of Gastroenterology
https://read.qxmd.com/read/37952559/optimization-cellular-uptake-and-in-vivo-evaluation-of-eudragit-s100-coated-bile-salt-containing-liposomes-for-oral-colonic-delivery-of-5-aminosalicylic-acid
#34
JOURNAL ARTICLE
Hamid Alghurabi, Huda Jassim Muhammad, Tatsuaki Tagami, Koki Ogawa, Tetsuya Ozeki
Eudragit S100-coated bile salt-containing liposomes were prepared and optimized by experimenting with different variables, including bile salt type and concentration, and the method of incorporation into liposomes using a model hydrophilic compound, 5-aminosalicylic acid (5-ASA). After optimizing the formulation, cellular uptake, and animal pharmacokinetic experiments were performed. The inclusion of sodium glycocholate (SG) into liposomes decreased liposome particle size and entrapment efficiency significantly but had no effect on zeta potential...
November 10, 2023: International Journal of Pharmaceutics
https://read.qxmd.com/read/37950138/water-soluble-se-containing-proteins-from-chicken-alleviate-dss-induced-ulcerative-colitis-in-mice-via-inhibiting-tlr4-myd88-pathway-and-protecting-the-goblet-cell-pathway
#35
JOURNAL ARTICLE
Yuancheng Li, Yanlong Xu, Xin Hu, Chenxi Li, Lulu Wei, Xinlei Wang, Yi Jin, Zhongqiu Hu
The influence of water-soluble selenium-containing proteins (WSSeP) in chicken on ulcerative colitis (UC) is not known. This work aims to investigate the effect of two WSSeP including h-Se with 1.78 μg Se/g and l-Se with 1.04 μg Se/g on mice UC induced by dextran sodium sulfate (DSS) versus 5-aminosalicylic acid (5-ASA). Seventy C57BL/6 mice were randomly divided into seven groups: groups 1 and 7 were given normal saline. Group 2 to group 4 were administrated orally 500, 1500, and 3000 mg/kg/day h-Se, respectively...
November 11, 2023: Biological Trace Element Research
https://read.qxmd.com/read/37930572/chicoric-acid-enhances-the-antioxidative-defense-system-and-protects-against-inflammation-and-apoptosis-associated-with-the-colitis-model-induced-by-dextran-sulfate-sodium-in-rats
#36
JOURNAL ARTICLE
Fahad Alharthi
Although several anticolitic drugs are available, their application is associated with numerous side effects. Chicoric acid (CA) is a hydroxycinnamic acid found naturally in chicory (Cichorium intybus), purple coneflower (Echinacea purpurea), and basil with numerous health benefits, such as antioxidative and anti-inflammatory activities. Here, the potential anticolitic efficiency of CA against dextran sulfate sodium (DSS)-induced colitis in rats was examined in rats. Animals were randomly assigned to the following five groups: control, CA (100 mg/kg body weight), DSS [(DSS); 4% w/v], CA + DSS (100 mg/kg), and the 5-aminosalicylic acid (100 mg/kg) + DSS group...
December 2023: Environmental Science and Pollution Research International
https://read.qxmd.com/read/37928972/refractory-intestinal-beh%C3%A3-et-like-disease-associated-with-trisomy-8-myelodysplastic-syndrome-resolved-by-parenteral-nutrition
#37
Ryo Takahashi, Yasuo Matsubara, Satoshi Takahashi, Kazuaki Yokoyama, Lim Lay Ahyoung, Michiko Koga, Hiroyuki Sakamoto, Narikazu Boku, Dai Shida, Hiroshi Yotsuyanagi
Intestinal Behçet disease (BD), associated with myelodysplastic syndrome (MDS), is often refractory to treatment. An 80-year-old man with trisomy 8 MDS (refractory anemia) developed intermittent fever. Despite investigations to exclude infectious disease, autoimmune disease, and malignancy as the cause of the fever, the etiology could not be determined. A colonoscopy revealed several shallow round ulcers in the ileocecal region and ascending colon, and the biopsy specimens showed nonspecific inflammation...
2023: Case Reports in Gastroenterology
https://read.qxmd.com/read/37928969/a-patient-with-crohn-s-disease-who-gave-birth-despite-sigmoid-volvulus-venous-thrombosis-nontraumatic-fracture-of-the-rib-and-sepsis-during-pregnancy
#38
Ayumi Ito, Maria Yonezawa, Shun Murasugi, Teppei Omori, Shinichi Nakamura, Katsutoshi Tokushige
The patient was a woman in her 40s who was diagnosed with Crohn's disease (CD) of the large and small intestines in 1996. In 2005, she was referred to our hospital for treatment. We treated her for 17 years with corticosteroids, biologics, immunosuppressive agents, 5-aminosalicylic acid, and nutrition care. However, her Crohn's Disease Activity Index remained between 200 and 250, indicating refractory CD. During her medical treatment, the patient also underwent 3 operations. One year ago, the patient became pregnant through in vitro fertilization...
2023: Case Reports in Gastroenterology
https://read.qxmd.com/read/37926993/upadacitinib-as-a-rescue-therapy-in-acute-severe-ulcerative-colitis-a-case-report-and-review-of-the-literature
#39
REVIEW
Nargess Mahmoud Ali, Mohammad Abdullah Shehab
BACKGROUND Ulcerative colitis (UC) is a chronic immune-mediated disease of the colon. The mainstay of treatment to achieve and maintain remission is 5-aminosalicylic acid (5-ASA). At least 20% of patients with UC experience an acute severe ulcerative colitis (ASUC) flare, requiring aggressive early intervention to prevent complications. The first-line treatment of ASUC is intravenous steroids followed by infliximab or cyclosporin in patients for whom steroids fail. Refractory disease failing medical therapy and warranting surgery is common...
November 6, 2023: American Journal of Case Reports
https://read.qxmd.com/read/37902927/management-of-ulcerative-colitis-by-dichloroacetate-impact-on-nfatc1-nlrp3-il1b-signaling-based-on-bioinformatics-analysis-combined-with-in-vivo-experimental-verification
#40
JOURNAL ARTICLE
Esraa Abdel-Nassir Abdel-Razek, Heba M Mahmoud, Amany A Azouz
The inflammatory response in ulcerative colitis (UC) could be relieved by the conventional immunomodulatory agents; 5-aminosalicylic acid, corticosteroids, or azathioprine. However, the low remission rates and the intolerance to these agents necessitate investigation of gene expression signature in UC that could influence the therapeutic efficacy of drugs, as well as the interference with persistence genes by novel therapeutic option. Three microarray datasets (GSE66407, GSE38713 and GSE14580) from the NCBI-GEO database were utilized...
October 30, 2023: Inflammopharmacology
keyword
keyword
35711
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.